{"auto_keywords": [{"score": 0.04798652790106826, "phrase": "disease_mutations"}, {"score": 0.04597768843054382, "phrase": "biomarker_discovery"}, {"score": 0.00481495049065317, "phrase": "significant_network_modules"}, {"score": 0.0039380388343479384, "phrase": "clinical_and_phenotypic_information"}, {"score": 0.0036826452656927877, "phrase": "drug_response"}, {"score": 0.0035216195857272403, "phrase": "patient_survival"}, {"score": 0.003293142761521422, "phrase": "important_goal"}, {"score": 0.0031490944606172152, "phrase": "personalized_cancer_genomics"}, {"score": 0.002633055347333953, "phrase": "hypermodules"}, {"score": 0.0024620842899061614, "phrase": "network_search_algorithm"}, {"score": 0.0022013916728990564, "phrase": "gene_modules"}, {"score": 0.0021049977753042253, "phrase": "significant_clinical_or_phenotypic_signatures"}], "paper_keywords": [""], "paper_abstract": "Correlating disease mutations with clinical and phenotypic information such as drug response or patient survival is an important goal of personalized cancer genomics and a first step in biomarker discovery. HyperModules is a network search algorithm that finds frequently mutated gene modules with significant clinical or phenotypic signatures from biomolecular interaction networks.", "paper_title": "HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery", "paper_id": "WOS:000340049100026"}